Occurrence of acute cholinergic syndrome in an infant due to donepezil ingestion

Donepezil and acetyl cholinesterase inhibitors are the most commonly prescribed medications for the treatment of Alzheimer's disease. We describe a 2‐year‐old infant who was referred to the emergency department after developing cholinergic syndrome 6 hours after ingesting 10 mg of his grandmoth...

Descripción completa

Detalles Bibliográficos
Autores principales: Sadeghi, Mahdieh, Zakariaei, Zakaria, Soleymani, Mostafa, Malakian, Abdollah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859403/
https://www.ncbi.nlm.nih.gov/pubmed/35369389
http://dx.doi.org/10.1002/ccr3.5469
_version_ 1784654452617117696
author Sadeghi, Mahdieh
Zakariaei, Zakaria
Soleymani, Mostafa
Malakian, Abdollah
author_facet Sadeghi, Mahdieh
Zakariaei, Zakaria
Soleymani, Mostafa
Malakian, Abdollah
author_sort Sadeghi, Mahdieh
collection PubMed
description Donepezil and acetyl cholinesterase inhibitors are the most commonly prescribed medications for the treatment of Alzheimer's disease. We describe a 2‐year‐old infant who was referred to the emergency department after developing cholinergic syndrome 6 hours after ingesting 10 mg of his grandmother's donepezil tablets and was finally discharged in stable condition.
format Online
Article
Text
id pubmed-8859403
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-88594032022-03-31 Occurrence of acute cholinergic syndrome in an infant due to donepezil ingestion Sadeghi, Mahdieh Zakariaei, Zakaria Soleymani, Mostafa Malakian, Abdollah Clin Case Rep Case Reports Donepezil and acetyl cholinesterase inhibitors are the most commonly prescribed medications for the treatment of Alzheimer's disease. We describe a 2‐year‐old infant who was referred to the emergency department after developing cholinergic syndrome 6 hours after ingesting 10 mg of his grandmother's donepezil tablets and was finally discharged in stable condition. John Wiley and Sons Inc. 2022-02-20 /pmc/articles/PMC8859403/ /pubmed/35369389 http://dx.doi.org/10.1002/ccr3.5469 Text en © 2022 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Reports
Sadeghi, Mahdieh
Zakariaei, Zakaria
Soleymani, Mostafa
Malakian, Abdollah
Occurrence of acute cholinergic syndrome in an infant due to donepezil ingestion
title Occurrence of acute cholinergic syndrome in an infant due to donepezil ingestion
title_full Occurrence of acute cholinergic syndrome in an infant due to donepezil ingestion
title_fullStr Occurrence of acute cholinergic syndrome in an infant due to donepezil ingestion
title_full_unstemmed Occurrence of acute cholinergic syndrome in an infant due to donepezil ingestion
title_short Occurrence of acute cholinergic syndrome in an infant due to donepezil ingestion
title_sort occurrence of acute cholinergic syndrome in an infant due to donepezil ingestion
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859403/
https://www.ncbi.nlm.nih.gov/pubmed/35369389
http://dx.doi.org/10.1002/ccr3.5469
work_keys_str_mv AT sadeghimahdieh occurrenceofacutecholinergicsyndromeinaninfantduetodonepezilingestion
AT zakariaeizakaria occurrenceofacutecholinergicsyndromeinaninfantduetodonepezilingestion
AT soleymanimostafa occurrenceofacutecholinergicsyndromeinaninfantduetodonepezilingestion
AT malakianabdollah occurrenceofacutecholinergicsyndromeinaninfantduetodonepezilingestion

Ejemplares similares